Moderate-to-severe Atopic Dermatitis Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd200 enrolled2 locationsNCT07321951
Recruiting
Phase 2
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd75 enrolled1 locationNCT07211542